Please do not adjust margins
ChemComm
Page 4 of 5
COMMUNICATION
Journal Name
7
8
.
.
990, 31, 1371-1375.
W. C. Lee, K. Y. Lin, C. M. Chen, Z. T. Chen, H. J. Liu and Y. K. Lai, J. Cell.
Physiol., 1991, 149, 66-76.
sepharose beads. DTT remarkably abolished the interaction
between beads and SERCA2 (Fig. 4D), suggesting that WA might
covalently bind to the sulfhydryl of cysteine on SERCA2.
1
DOI: 10.1039/C9CC03653A
As the main pump that transports Ca2+ from cytoplasm to ER, 9. L. Sun, J. Liu, D. Cui, J. Li, Y. Yu, L. Ma and L. Hu, J. Cell. Biochem., 2010,
SERCA dependent calcium transport is important to maintain the
109, 532-541.
2
+
10. L. Sun, J. Liu, P. Liu, Y. Yu, L. Ma and L. Hu, Process Biochem., 2011, 46,
calcium homeostasis and keep the concentration of Ca in ER four
4
82-488.
2
6
orders of magnitude higher than that in cytosol. Various cancer
1
1. W. C. Lee, Y. C. Lee, M. D. Perng, C. M. Chen and Y. K. Lai, J. Cell.
Biochem., 1993, 52, 253-265.
2
+
27
cells exhibit dysregulated Ca signaling and overexpression of
SERCA activates cell survival pathways through the effect on cellular 12. S. M. DeGuire, D. C. Earl, Y. Du, B. A. Crews, A. T. Jacobs, A. Ustione, C.
2
+
28-30
Daniel, K. M. Chong, L. J. Marnett, D. W. Piston, B. O. Bachmann and G.
A. Sulikowski, Angew. Chem. Int. Ed., 2015, 54, 961-964.
3. C. Li, T. Dong, Q. Li and X. Lei, Angew. Chem. Int. Ed., 2014, 53, 12111-
Ca peak and oscillations in various cancers,
which make it a
3
1
potential target for antitumor therapy. To test the effects of WA
on SERCA activity, MDA-MB-231 cells were incubated with WA and
the Ca -ATPase activity was measured using Ca -ATPase kit. The 14. H. Shi, C.-J. Zhang, G. Y. J. Chen and S. Q. Yao, J. Am. Chem. Soc., 2012,
result indicated WA significantly inhibited the Ca -ATPase activity
in a dose-dependent manner (Fig. 4E), and 8 μM of WA inhibited
1
1
2115.
2
+
2+
2
+
134, 3001-3014.
1
5. Z. Li, P. Hao, L. Li, C. Y. J. Tan, X. Cheng, G. Y. J. Chen, S. K. Sze, H.-M.
Shen and S. Q. Yao, Angewandte Chemie-International Edition, 2013, 52,
2
+
the Ca -ATPase activity by 62%.
8
551-8556.
It is reported the inhibition of SERCA activity often results in an 16. S. Pan, H. Zhang, C. Wang, S. C. L. Yao and S. Q. Yao, Natural product
imbalance of calcium levels in cancer cells, which causes unfolded
protein response (UPR), ER stress and eventually apoptosis.32 Thus
the effects of WA were tested on the ER stress-associated markers
and apoptotic signalling pathway in MDA-MB-231 cells. WA
reports, 2016, 33, 612-620.
17. E. M. Sletten and C. R. Bertozzi, Angewandte Chemie-International
Edition, 2009, 48, 6974-6998.
1
8. F. Wolbers, P. ter Braak, S. Le Gac, R. Luttge, H. Andersson, I. Vermes
and A. van den Berg, Electrophoresis, 2006, 27, 5073-5080.
treatment significantly caused a markedly enhanced expression of 19. Y.-M. Xu, A. D. Brooks, E. M. K. Wijeratne, C. J. Henrich, P. Tewary, T. J.
Sayers and A. A. L. Gunatilaka, J. Med. Chem., 2017, 60, 3039-3051.
GRP78, ATF4, P-eIF2α and CHOP, as well as the cleavage of PARP in
2
0. E. M. K. Wijeratne, Y.-M. Xu, R. Scherz-Shouval, M. T. Marron, D. D.
Rocha, M. X. Liu, L. V. Costa-Lotufo, S. Santagata, S. Lindquist, L.
Whitesell and A. A. L. Gunatilaka, J. Med. Chem., 2014, 57, 2851-2863.
a dose-dependent manner (Fig. 4F). These results indicated WA
could act against cancer cell through inhibiting SERCA activity and
inducing ER stress-associated apoptosis.
21. G. G. Llanos, L. M. Araujo, I. A. Jimenez, L. M. Moujir, J. Rodriguez, C.
In conclusion, we developed four new WA-based fluorescent
probes to explore its subcellular distribution and found ER was the
main organelle WA located in, through chemical proteomics-based
target identification and molecule/cell-based validation, we
Jimenez and I. L. Bazzocchi, Eur. J. Med. Chem., 2017, 140, 52-64.
2. S. Xu, S. Luo, H. Yao, H. Cai, X. Miao, F. Wu, D.-H. Yang, X. Wu, W. Xie, H.
Yao, Z.-S. Chen and J. Xu, J. Med. Chem., 2016, 59, 5022-5034.
2
2
3. Q. Sun, J. Qian, H. Tian, L. Duan and W. Zhang, Chem. Commun., 2014,
5
0, 8518-8521.
elucidated that WA targets SERCA2, inhibits its activity and finally 24. K. Sivakumar, F. Xie, B. M. Cash, S. Long, H. N. Barnhill and Q. Wang,
Org. Lett., 2004, 6, 4603-4606.
5. L. Liu, Y. Hua, D. Wang, L. Shan, Y. Zhang, J. Zhu, H. Jin, H. Li, Z. Hu and
W. Zhang, Chem. Biol., 2014, 21, 1415-1415.
6. M. Periasamy and A. Kalyanasundaram, Muscle & Nerve, 2007, 35, 430-
442.
7. J. A. Rosado, P. C. Redondo, J. A. Pariente and G. M. Salido, Cancer
Ther., 2004, 2, 263-270.
8. B. Papp, J.-P. Brouland, A. Arbabian, P. Gelebart, T. Kovacs, R. Bobe, J.
Enouf, N. Varin-Blank and A. Apati, Biomolecules, 2012, 2, 165-186.
9. G. R. Monteith, D. McAndrew, H. M. Faddy and S. J. Roberts-Thomson,
Nat. Rev. Cancer 2007, 7, 519-530.
causes ER stress-associated apoptosis in MDA-MB-231 cells. This
2
2
2
2
2
work highlighted a new strategy to find the cellular target of
bioactive natural product more accurately through the combination
of affinity-based proteome profiling and fluorescent imaging and
could help to understand the antitumor activity of WA and the
related derivatives.
This research was financially supported by the Open Project of
State Key Laboratory of Natural Medicines (No. SKLNMZZCX
2
8
0
01815), the National Natural Science Foundation of China (No.
1872983) and the Drug Innovation Major Project (2018ZX09711- 30. L. Wang, L. Wang, R. Song, Y. Shen, Y. Sun, Y. Gu, Y. Shu and Q. Xu, Mol.
01-007).
Cancer Ther., 2011, 10, 461-471.
3
3
1. S. B. Christensen, D. M. Skytte, S. R. Denmeade, C. Dionne, J. V. Moller,
P. Nissen and J. T. Isaacs, Anti-Cancer Agent. Me., 2009, 9, 276-294.
2. S. Orrenius, B. Zhivotovsky and P. Nicotera, Nat. Rev. Mol. Cell Bio.,
Notes and references
2
003, 4, 552-565.
1
2
3
4
5
6
.
.
.
.
.
.
J. Khazir, D. L. Riley, L. A. Pilcher, P. De-Maayer and B. A. Mir, Natural
product communications, 2014, 9, 1655-1669.
M. S. Butler, A. A. Robertson and M. A. Cooper, Nat. Prod. Rep., 2014,
3
1, 1612-1661.
G.-X. Yang, G.-L. Ma, H. Li, T. Huang, J. Xiong and J.-F. Hu, Chin. J. Nat.
Medicines, 2018, 16, 881-906.
Y. S. Lin, H. C. Chiang, W. S. Kan, E. Hone, S. J. Shih and M. H. Won, Am.
J. Chin. Med., 1992, 20, 233-243.
A. G. Damu, P.-C. Kuo, C.-R. Su, T.-H. Kuo, T.-H. Chen, K. F. Bastow, K.-H.
Lee and T.-S. Wu, J. Nat. Prod., 2007, 70, 1146-1152.
H. I. F. Magalhaes, M. L. Veras, M. R. Torres, A. Alves, O. D. L. Pessoa, E.
R. Silveira, L. V. Costa-Lotufo, M. O. de Moraes and C. Pessoa, J. Pharm.
Pharmacol., 2006, 58, 235-241.
4
| J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins